ARTICLE | Clinical News
Idelvion albutrepenonacog alfa regulatory update
May 16, 2016 7:00 AM UTC
The European Commission approved Idelvion albutrepenonacog alfa from CSL for the treatment and prophylaxis of bleeding in patients with hemophilia B. The company said Idelvion will be launched in Euro...